Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
26.74
-2.78 (-9.42%)
At close: Apr 1, 2025, 4:00 PM
26.66
-0.08 (-0.30%)
After-hours: Apr 1, 2025, 4:06 PM EDT

Avidity Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Market Capitalization
3,2143,4706711,4741,115958
Upgrade
Market Cap Growth
417.36%417.36%-54.52%32.27%16.40%-
Upgrade
Enterprise Value
1,9751,8891391,080703617
Upgrade
Last Close Price
29.5229.089.0522.1923.7725.52
Upgrade
PS Ratio
318.37318.3970.15159.85119.53141.10
Upgrade
PB Ratio
2.482.441.342.552.923.13
Upgrade
P/TBV Ratio
2.442.441.342.552.923.13
Upgrade
EV/Sales Ratio
181.21173.3114.50117.1175.3590.94
Upgrade
Debt / Equity Ratio
0.010.010.020.020.030.00
Upgrade
Asset Turnover
0.010.010.020.020.020.03
Upgrade
Quick Ratio
15.6115.617.4911.8413.7022.58
Upgrade
Current Ratio
15.7415.747.5812.0013.8622.74
Upgrade
Return on Equity (ROE)
-33.47%-33.47%-39.34%-36.27%-34.32%-23.62%
Upgrade
Return on Assets (ROA)
-21.60%-21.60%-23.24%-20.97%-19.38%-12.85%
Upgrade
Return on Capital (ROIC)
-24.39%-24.39%-26.79%-22.78%-21.07%-14.51%
Upgrade
Earnings Yield
-9.29%-9.29%-31.65%-11.80%-10.59%-4.63%
Upgrade
FCF Yield
-8.88%-8.88%-18.39%-9.43%-8.84%-3.99%
Upgrade
Buyback Yield / Dilution
-52.83%-52.83%-39.97%-25.91%-91.24%-698.49%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q